Figure 1. Images of two fibres during stimulation and followed by recovery with or without GSK3β inhibitor.
A and B, fibres expressing NFATc1–GFP are shown in Ringer solution at room temperature 10 min prior to (−10), 60 min during (stimulation, 0–60) and 90 min after (recovery, 10–90) electrical stimulation for recovery in the presence of either the solvent DMSO (A) or 20 μm GSK3β inhibitor alsterpaullone (B). Scale bar, 20 μm.